Methylation-mediated regulation of E2F1 in DNA damage-induced cell death

Journal of Receptors and Signal Transduction

Volumn 31, Issue 2, 2011, Pages 139-146

  Xie, Qi ^a   Bai, Yujie ^a   Wu, Junbing ^a   Sun, Yu ^a   Wang, Yadong ^a   Zhang, Ye ^b   Mei, Pinchao ^b   Yuan, Zengqiang ^a  

^a INSTITUTE OF BIOPHYSICS   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

apoptosis; Methylation; signal transduction

Indexed keywords

BIM PROTEIN; LYSINE; METHYLTRANSFERASE; PROTEIN P73; SET9 ENZYME; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG;

ARTICLE; CELL DEATH; DEMETHYLATION; DNA BINDING; DNA DAMAGE; DNA METHYLATION; GENE CONTROL; GENE TARGETING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PROTEIN DOMAIN;

AMINO ACID SEQUENCE; CELL DEATH; CELL LINE; DNA DAMAGE; E2F1 TRANSCRIPTION FACTOR; GENE KNOCKDOWN TECHNIQUES; HISTONE DEMETHYLASES; HISTONE-LYSINE N-METHYLTRANSFERASE; HUMANS; LACTATES; LYSINE; METHYLATION; MOLECULAR SEQUENCE DATA; PHENOLS; PROTEIN STABILITY; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79952599834     PISSN: 10799893     EISSN: 15324281     Source Type: Journal    
DOI: 10.3109/10799893.2011.552914     Document Type: Article

References (34)

1. Rogoff HA, Kowalik TF. Life, death and E2F: linking proliferation control and DNA damage signaling via E2F1. Cell Cycle 2004, 3, 845-846. (Pubitemid 40179454)
2. Inoshita S, Terada Y, Nakashima O, Kuwahara M, Sasaki S, Marumo F. Regulation of the G1/S transition phase in mesangial cells by E2F1. Kidney Int 1999, 56, 1238-1241. (Pubitemid 29451219)
3. Stiewe T, Pützer BM. Role of the p53-homologue p73 in E2F1- induced apoptosis. Nat Genet 2000, 26, 464-469.
4. Zhao Y, Tan J, Zhuang L, Jiang X, Liu ET, Yu Q. Inhibitors of histone deacetylases target the Rb-E2F1 pathway for apoptosis induction through activation of proapoptotic protein Bim. Proc Natl Acad Sci USA 2005, 102, 16090-16095. (Pubitemid 41552872)
5. Lin WC, Lin FT, Nevins JR. Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation. Genes Dev 2001, 15, 1833-1844. (Pubitemid 32905640)
6. Martínez-Balbás MA, Bauer UM, Nielsen SJ, Brehm A, Kouzarides T. Regulation of E2F1 activity by acetylation. EMBO J 2000, 19, 662-671. (Pubitemid 30093739)
7. Huang J, Berger SL. The emerging field of dynamic lysine methylation of non-histone proteins. Curr Opin Genet Dev 2008, 18, 152-158. (Pubitemid 351749824)
8. Kouskouti A, Scheer E, Staub A, Tora L, Talianidis I. Gene-specific modulation of TAF10 function by SET9-mediated methylation. Mol Cell 2004, 14, 175-182. (Pubitemid 38515645)
9. Chuikov S, Kurash JK, Wilson JR, Xiao B, Justin N, Ivanov GS, McKinney K, Tempst P, Prives C, Gamblin SJ, Barlev NA, Reinberg D. Regulation of p53 activity through lysine methylation. Nature 2004, 432, 353-360. (Pubitemid 39551664)
10. Estève PO, Chin HG, Benner J, Feehery GR, Samaranayake M, Horwitz GA, Jacobsen SE, Pradhan S. Regulation of DNMT1 stability through SET7-mediated lysine methylation in mammalian cells. Proc Natl Acad Sci USA 2009, 106, 5076-5081.
11. Shi Y, Lan F, Matson C, Mulligan P, Whetstine JR, Cole PA, Casero RA, Shi Y. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 2004, 119, 941-953 (Pubitemid 40037608)
12. Nicholson TB, Chen T. LSD1 demethylates histone and nonhistone proteins. Epigenetics 2009, 4, 129-132.
13. Huang J, Sengupta R, Espejo AB, Lee MG, Dorsey JA, Richter M, Opravil S, Shiekhattar R, Bedford MT, Jenuwein T, Berger SL. p53 is regulated by the lysine demethylase LSD1. Nature 2007, 449, 105-108. (Pubitemid 47373772)
14. Wang J, Scully K, Zhu X, Cai L, Zhang J, Prefontaine GG, Krones A, Ohgi KA, Zhu P, Garcia-Bassets I, Liu F, Taylor H, Lozach J, Jayes FL, Korach KS, Glass CK, Fu XD, Rosenfeld MG. Opposing LSD1 complexes function in developmental gene activation and repression programmes. Nature 2007, 446, 882-887. (Pubitemid 46633160)
15. Bi W, Xiao L, Jia Y, Wu J, Xie Q, Ren J, Ji G, Yuan Z. c-Jun N-terminal kinase enhances MST1-mediated pro-apoptotic signaling through phosphorylation at serine 82. J Biol Chem 2010, 285, 6259-6264.
16. Ohtani K, DeGregori J, Nevins JR. Regulation of the cyclin E gene by transcription factor E2F1. Proc Natl Acad Sci USA 1995, 92, 12146-12150. (Pubitemid 26014027)
17. Couture JF, Collazo E, Hauk G, Trievel RC. Structural basis for the methylation site specificity of SET7/9. Nat Struct Mol Biol 2006, 13, 140-146. (Pubitemid 43214717)
18. Ivanov GS, Ivanova T, Kurash J, Ivanov A, Chuikov S, Gizatullin F, Herrera-Medina EM, Rauscher F 3rd, Reinberg D, Barlev NA. Methylation- acetylation interplay activates p53 in response to DNA damage. Mol Cell Biol 2007, 27, 6756-6769. (Pubitemid 47483627)
19. Morgunkova A, Barlev NA. Lysine methylation goes global. Cell Cycle 2006, 5, 1308-1312. (Pubitemid 43894286)
20. Wang J, Hevi S, Kurash JK, Lei H, Gay F, Bajko J, Su H, Sun W, Chang H, Xu G, Gaudet F, Li E, Chen T. The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation. Nat Genet 2009, 41, 125-129.
21. Shu HK, Julin CM, Furman F, Yount GL, Haas-Kogan D, Israel MA. Overexpression of E2F1 in glioma-derived cell lines induces a p53-independent apoptosis that is further enhanced by ionizing radiation. Neuro-oncology 2000, 2, 16-21.
22. Palacios G, Talos F, Nemajerova A, Moll UM, Petrenko O. E2F1 plays a direct role in Rb stabilization and p53-independent tumor suppression. Cell Cycle 2008, 7, 1776-1781. (Pubitemid 351988743)
23. Wang H, Cao R, Xia L, Erdjument-Bromage H, Borchers C, Tempst P, Zhang Y. Purification and functional characterization of a histone H3-lysine 4-specific methyltransferase. Mol Cell 2001, 8, 1207-1217. (Pubitemid 34084993)
24. Subramanian K, Jia D, Kapoor-Vazirani P, Powell DR, Collins RE, Sharma D, Peng J, Cheng X, Vertino PM. Regulation of estrogen receptor alpha by the SET7 lysine methyltransferase. Mol Cell 2008, 30, 336-347. (Pubitemid 351615317)
25. Ea CK, Baltimore D. Regulation of NF-kappaB activity through lysine monomethylation of p65. Proc Natl Acad Sci USA 2009, 106, 18972-18977.
26. Yang XD, Huang B, Li M, Lamb A, Kelleher NL, Chen LF. Negative regulation of NF-kappaB action by Set9-mediated lysine methylation of the RelA subunit. EMBO J 2009, 28, 1055-1066.
27. Kontaki H, Talianidis I. Lysine methylation regulates E2F1-induced cell death. Mol Cell 2010, 39, 152-160.
28. Senanayake MD, Amunugama H, Boncher TD, Casero RA, Woster PM. Design of polyamine-based therapeutic agents: new targets and new directions. Essays Biochem 2009, 46, 77-94.
29. Mimasu S, Umezawa N, Sato S, Higuchi T, Umehara T, Yokoyama S. Structurally designed trans-2-phenylcyclopropylamine derivatives potently inhibit histone demethylase LSD1/KDM1. Biochemistry 2010, 49, 6494-6503.
30. Huang Y, Greene E, Murray Stewart T, Goodwin AC, Baylin SB, Woster PM, Casero RA Jr. Inhibition of lysine-specific demethylase 1 by polyamine analogues results in reexpression of aberrantly silenced genes. Proc Natl Acad Sci USA 2007, 104, 8023-8028. (Pubitemid 47185869)
31. Huang Y, Stewart TM, Wu Y, Baylin SB, Marton LJ, Perkins B, Jones RJ, Woster PM, Casero RA Jr. Novel oligoamine analogues inhibit lysine-specific demethylase 1 and induce reexpression of epigenetically silenced genes. Clin Cancer Res 2009, 15, 7217-7228.
32. Magerl C, Ellinger J, Braunschweig T, Kremmer E, Koch LK, Höller T, Büttner R, Lüscher B, Gütgemann I. H3K4 dimethylation in hepatocellular carcinoma is rare compared with other hepatobiliary and gastrointestinal carcinomas and correlates with expression of the methylase Ash2 and the demethylase LSD1. Hum Pathol 2010, 41, 181-189.
33. Lin T, Ponn A, Hu X, Law BK, Lu J. Requirement of the histone demethylase LSD1 in Snai1-mediated transcriptional repression during epithelial-mesenchymal transition. Oncogene 2010, 29, 4896-4904.
34. Lim S, Janzer A, Becker A, Zimmer A, Schüle R, Buettner R, Kirfel J. Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology. Carcinogenesis 2010, 31, 512-520.